nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—SLC22A7—Fluorouracil—skin cancer	0.205	0.269	CbGbCtD
Oxtriphylline—CYP1A2—Imiquimod—skin cancer	0.18	0.237	CbGbCtD
Oxtriphylline—SLC22A7—Docetaxel—skin cancer	0.157	0.206	CbGbCtD
Oxtriphylline—CYP1A2—Vemurafenib—skin cancer	0.0989	0.13	CbGbCtD
Oxtriphylline—CYP1A2—Dacarbazine—skin cancer	0.0758	0.0996	CbGbCtD
Oxtriphylline—CYP1A2—Fluorouracil—skin cancer	0.0444	0.0584	CbGbCtD
Oxtriphylline—PDE3A—penis—skin cancer	0.0148	0.162	CbGeAlD
Oxtriphylline—ADORA1—nerve—skin cancer	0.0066	0.0724	CbGeAlD
Oxtriphylline—HDAC2—hair follicle—skin cancer	0.00546	0.0599	CbGeAlD
Oxtriphylline—ADORA2B—nipple—skin cancer	0.00522	0.0572	CbGeAlD
Oxtriphylline—PDE3B—connective tissue—skin cancer	0.00447	0.049	CbGeAlD
Oxtriphylline—HDAC2—neck—skin cancer	0.00366	0.0402	CbGeAlD
Oxtriphylline—ADORA2B—mammalian vulva—skin cancer	0.00305	0.0334	CbGeAlD
Oxtriphylline—PDE4B—nipple—skin cancer	0.00277	0.0304	CbGeAlD
Oxtriphylline—HDAC2—connective tissue—skin cancer	0.00263	0.0288	CbGeAlD
Oxtriphylline—PDE4C—head—skin cancer	0.00249	0.0273	CbGeAlD
Oxtriphylline—HDAC2—epithelium—skin cancer	0.00249	0.0273	CbGeAlD
Oxtriphylline—HDAC2—skin of body—skin cancer	0.00237	0.026	CbGeAlD
Oxtriphylline—ADORA2A—lymphoid tissue—skin cancer	0.00225	0.0247	CbGeAlD
Oxtriphylline—ADORA2B—head—skin cancer	0.00218	0.0239	CbGeAlD
Oxtriphylline—ADORA2A—female reproductive system—skin cancer	0.00217	0.0238	CbGeAlD
Oxtriphylline—PDE3A—female reproductive system—skin cancer	0.00192	0.0211	CbGeAlD
Oxtriphylline—HDAC2—lymphoid tissue—skin cancer	0.00192	0.021	CbGeAlD
Oxtriphylline—ADORA1—female reproductive system—skin cancer	0.00188	0.0206	CbGeAlD
Oxtriphylline—HDAC2—female reproductive system—skin cancer	0.00185	0.0203	CbGeAlD
Oxtriphylline—PDE3B—lymph node—skin cancer	0.00184	0.0202	CbGeAlD
Oxtriphylline—ADORA2A—head—skin cancer	0.00181	0.0199	CbGeAlD
Oxtriphylline—CYP1A2—nipple—skin cancer	0.0017	0.0187	CbGeAlD
Oxtriphylline—PDE4B—mammalian vulva—skin cancer	0.00162	0.0178	CbGeAlD
Oxtriphylline—ADORA1—head—skin cancer	0.00157	0.0172	CbGeAlD
Oxtriphylline—HDAC2—head—skin cancer	0.00155	0.017	CbGeAlD
Oxtriphylline—PDE4D—lymph node—skin cancer	0.00154	0.0169	CbGeAlD
Oxtriphylline—PDE4B—lymphoid tissue—skin cancer	0.00144	0.0158	CbGeAlD
Oxtriphylline—PDE4B—female reproductive system—skin cancer	0.00139	0.0152	CbGeAlD
Oxtriphylline—PDE4A—lymph node—skin cancer	0.00136	0.0149	CbGeAlD
Oxtriphylline—PDE4B—head—skin cancer	0.00116	0.0127	CbGeAlD
Oxtriphylline—PDE3A—lymph node—skin cancer	0.00113	0.0123	CbGeAlD
Oxtriphylline—ADORA1—lymph node—skin cancer	0.0011	0.012	CbGeAlD
Oxtriphylline—HDAC2—lymph node—skin cancer	0.00108	0.0119	CbGeAlD
Oxtriphylline—PDE4B—lymph node—skin cancer	0.000811	0.00889	CbGeAlD
Oxtriphylline—PDE3B—Signaling Pathways—SUFU—skin cancer	0.000166	0.00112	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—GLI1—skin cancer	0.000164	0.00111	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SUFU—skin cancer	0.000163	0.0011	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—GLI2—skin cancer	0.000163	0.0011	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MC1R—skin cancer	0.000161	0.00109	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—GLI2—skin cancer	0.000161	0.00109	CbGpPWpGaD
Oxtriphylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—skin cancer	0.000161	0.00109	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—GLI1—skin cancer	0.000159	0.00108	CbGpPWpGaD
Oxtriphylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000158	0.00107	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TP53—skin cancer	0.000157	0.00107	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MC1R—skin cancer	0.000155	0.00105	CbGpPWpGaD
Oxtriphylline—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	0.000155	0.00105	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SUFU—skin cancer	0.000155	0.00105	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MC1R—skin cancer	0.000154	0.00104	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—GLI1—skin cancer	0.000153	0.00104	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—GLI1—skin cancer	0.000151	0.00103	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SUFU—skin cancer	0.000151	0.00102	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—PTGER4—skin cancer	0.000147	0.000997	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SUFU—skin cancer	0.000145	0.000985	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—SHH—skin cancer	0.000145	0.000981	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SUFU—skin cancer	0.000143	0.000973	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SHH—skin cancer	0.000143	0.000968	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—RASA1—skin cancer	0.000142	0.000962	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—TP53—skin cancer	0.000142	0.000961	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.00014	0.000951	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PTCH1—skin cancer	0.000137	0.00093	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—SMO—skin cancer	0.000137	0.00093	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—GLI2—skin cancer	0.000135	0.000917	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PTCH1—skin cancer	0.000135	0.000917	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SMO—skin cancer	0.000135	0.000917	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—PTGER4—skin cancer	0.000134	0.000906	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—PTGER4—skin cancer	0.000132	0.000893	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—SHH—skin cancer	0.000131	0.00089	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ENO2—skin cancer	0.000131	0.00089	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SHH—skin cancer	0.00013	0.000883	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—IL6—skin cancer	0.00013	0.00088	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—RASA1—skin cancer	0.000129	0.000878	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000129	0.000876	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MC1R—skin cancer	0.000129	0.000875	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—GLI1—skin cancer	0.000127	0.000863	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SHH—skin cancer	0.000126	0.000856	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—GLI2—skin cancer	0.000126	0.000853	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RASA1—skin cancer	0.000126	0.000851	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SHH—skin cancer	0.000124	0.000842	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SMO—skin cancer	0.000123	0.000837	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PTCH1—skin cancer	0.000123	0.000837	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RASA1—skin cancer	0.000123	0.000837	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.000121	0.000818	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SUFU—skin cancer	0.000121	0.000818	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—PTGER4—skin cancer	0.00012	0.000815	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MC1R—skin cancer	0.00012	0.000814	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PTCH1—skin cancer	0.00012	0.000812	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SMO—skin cancer	0.00012	0.000812	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SHH—skin cancer	0.000118	0.000802	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—GLI1—skin cancer	0.000118	0.000802	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PTCH1—skin cancer	0.000118	0.000799	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SMO—skin cancer	0.000118	0.000799	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—TP53—skin cancer	0.000118	0.000798	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RASA1—skin cancer	0.000118	0.000797	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—PTGER4—skin cancer	0.000117	0.00079	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—FOXO4—skin cancer	0.000116	0.000789	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000116	0.000789	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—NRAS—skin cancer	0.000116	0.000787	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SHH—skin cancer	0.000115	0.00078	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—PTGER4—skin cancer	0.000115	0.000777	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RASA1—skin cancer	0.000114	0.000775	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTCH1—skin cancer	0.000112	0.00076	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SMO—skin cancer	0.000112	0.00076	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SUFU—skin cancer	0.000112	0.00076	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000111	0.000754	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SHH—skin cancer	0.000111	0.000751	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RASA1—skin cancer	0.00011	0.000746	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SHH—skin cancer	0.000109	0.000742	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—TP53—skin cancer	0.000109	0.000742	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—PTGER4—skin cancer	0.000109	0.00074	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SMO—skin cancer	0.000109	0.000739	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTCH1—skin cancer	0.000109	0.000739	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RASA1—skin cancer	0.000109	0.000737	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—NRAS—skin cancer	0.000108	0.000731	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—IL6—skin cancer	0.000108	0.00073	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—FOXO4—skin cancer	0.000107	0.000726	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—FOXO4—skin cancer	0.000106	0.00072	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—PTGER4—skin cancer	0.000106	0.00072	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTCH1—skin cancer	0.000105	0.000712	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SMO—skin cancer	0.000105	0.000712	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SMO—skin cancer	0.000104	0.000703	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTCH1—skin cancer	0.000104	0.000703	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—FOXO4—skin cancer	0.000103	0.000698	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000103	0.000696	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—PTGER4—skin cancer	0.000102	0.000693	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—FOXO4—skin cancer	0.000101	0.000687	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—PTGER4—skin cancer	0.000101	0.000685	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—NRAS—skin cancer	0.000101	0.000685	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—IL6—skin cancer	0.0001	0.000679	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—KRAS—skin cancer	9.99e-05	0.000677	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	9.82e-05	0.000666	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—FOXO4—skin cancer	9.64e-05	0.000654	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	9.45e-05	0.000641	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—FOXO4—skin cancer	9.38e-05	0.000636	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—KRAS—skin cancer	9.29e-05	0.00063	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SHH—skin cancer	9.2e-05	0.000624	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—NRAS—skin cancer	9.2e-05	0.000623	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RASA1—skin cancer	9.14e-05	0.00062	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—FOXO4—skin cancer	9.03e-05	0.000612	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—FOXO4—skin cancer	8.92e-05	0.000605	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SMO—skin cancer	8.72e-05	0.000591	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTCH1—skin cancer	8.72e-05	0.000591	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—KRAS—skin cancer	8.69e-05	0.000589	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SHH—skin cancer	8.55e-05	0.00058	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RASA1—skin cancer	8.5e-05	0.000576	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—HRAS—skin cancer	8.49e-05	0.000576	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PTGER4—skin cancer	8.49e-05	0.000575	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—ERCC2—skin cancer	8.22e-05	0.000557	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—IL6—skin cancer	8.13e-05	0.000551	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTCH1—skin cancer	8.11e-05	0.00055	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SMO—skin cancer	8.11e-05	0.00055	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—KRAS—skin cancer	7.91e-05	0.000537	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—HRAS—skin cancer	7.89e-05	0.000535	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PTGER4—skin cancer	7.89e-05	0.000535	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TERT—skin cancer	7.77e-05	0.000527	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TP53—skin cancer	7.72e-05	0.000524	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ERCC2—skin cancer	7.63e-05	0.000517	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—IL6—skin cancer	7.55e-05	0.000512	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—FOXO4—skin cancer	7.5e-05	0.000508	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—HRAS—skin cancer	7.39e-05	0.000501	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—NRAS—skin cancer	7.35e-05	0.000498	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TERT—skin cancer	7.15e-05	0.000485	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TERT—skin cancer	7.09e-05	0.000481	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TP53—skin cancer	7.03e-05	0.000477	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—FOXO4—skin cancer	6.97e-05	0.000473	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TERT—skin cancer	6.88e-05	0.000466	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TERT—skin cancer	6.77e-05	0.000459	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—HRAS—skin cancer	6.73e-05	0.000456	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—NRAS—skin cancer	6.55e-05	0.000444	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TERT—skin cancer	6.44e-05	0.000437	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—KRAS—skin cancer	6.33e-05	0.000429	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TERT—skin cancer	6.26e-05	0.000425	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—BRAF—skin cancer	6.15e-05	0.000417	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TERT—skin cancer	6.03e-05	0.000409	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—NRAS—skin cancer	5.97e-05	0.000405	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TERT—skin cancer	5.96e-05	0.000404	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—NRAS—skin cancer	5.79e-05	0.000393	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—NRAS—skin cancer	5.7e-05	0.000386	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—BRAF—skin cancer	5.66e-05	0.000384	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—KRAS—skin cancer	5.64e-05	0.000382	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—skin cancer	5.62e-05	0.000381	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—BRAF—skin cancer	5.62e-05	0.000381	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—BRAF—skin cancer	5.45e-05	0.000369	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—NRAS—skin cancer	5.43e-05	0.000368	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—HRAS—skin cancer	5.38e-05	0.000365	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—BRAF—skin cancer	5.36e-05	0.000363	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—NRAS—skin cancer	5.28e-05	0.000358	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLIN2—skin cancer	5.18e-05	0.000351	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—KRAS—skin cancer	5.14e-05	0.000349	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—BRAF—skin cancer	5.1e-05	0.000346	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—NRAS—skin cancer	5.08e-05	0.000344	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—NRAS—skin cancer	5.02e-05	0.00034	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TERT—skin cancer	5.01e-05	0.00034	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—KRAS—skin cancer	4.99e-05	0.000338	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—BRAF—skin cancer	4.96e-05	0.000336	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—KRAS—skin cancer	4.91e-05	0.000333	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—HRAS—skin cancer	4.79e-05	0.000325	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—BRAF—skin cancer	4.78e-05	0.000324	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—BRAF—skin cancer	4.72e-05	0.00032	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—KRAS—skin cancer	4.67e-05	0.000317	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TERT—skin cancer	4.66e-05	0.000316	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—skin cancer	4.58e-05	0.000311	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—skin cancer	4.57e-05	0.00031	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—KRAS—skin cancer	4.54e-05	0.000308	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—KRAS—skin cancer	4.37e-05	0.000296	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—HRAS—skin cancer	4.37e-05	0.000296	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—KRAS—skin cancer	4.32e-05	0.000293	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—HRAS—skin cancer	4.24e-05	0.000287	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—skin cancer	4.18e-05	0.000284	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CSPG4—skin cancer	4.18e-05	0.000283	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—HRAS—skin cancer	4.17e-05	0.000283	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—skin cancer	4.06e-05	0.000275	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—skin cancer	3.99e-05	0.000271	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—HRAS—skin cancer	3.97e-05	0.000269	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—BRAF—skin cancer	3.97e-05	0.000269	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—NRAS—skin cancer	3.92e-05	0.000266	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NRAS—skin cancer	3.87e-05	0.000262	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—HRAS—skin cancer	3.86e-05	0.000262	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—skin cancer	3.8e-05	0.000258	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—HRAS—skin cancer	3.72e-05	0.000252	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—skin cancer	3.7e-05	0.000251	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—BRAF—skin cancer	3.69e-05	0.00025	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—HRAS—skin cancer	3.67e-05	0.000249	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NRAS—skin cancer	3.56e-05	0.000241	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—skin cancer	3.56e-05	0.000241	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NRAS—skin cancer	3.53e-05	0.000239	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—skin cancer	3.51e-05	0.000238	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NRAS—skin cancer	3.42e-05	0.000232	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—KRAS—skin cancer	3.38e-05	0.000229	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NRAS—skin cancer	3.37e-05	0.000228	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KRAS—skin cancer	3.33e-05	0.000226	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NRAS—skin cancer	3.2e-05	0.000217	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NRAS—skin cancer	3.12e-05	0.000211	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KRAS—skin cancer	3.06e-05	0.000208	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KRAS—skin cancer	3.04e-05	0.000206	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NRAS—skin cancer	3e-05	0.000203	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NRAS—skin cancer	2.97e-05	0.000201	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—skin cancer	2.96e-05	0.000201	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KRAS—skin cancer	2.95e-05	0.0002	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KRAS—skin cancer	2.9e-05	0.000196	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—HRAS—skin cancer	2.87e-05	0.000195	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ENO2—skin cancer	2.84e-05	0.000192	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HRAS—skin cancer	2.83e-05	0.000192	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KRAS—skin cancer	2.76e-05	0.000187	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—skin cancer	2.75e-05	0.000186	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—skin cancer	2.71e-05	0.000184	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—skin cancer	2.7e-05	0.000183	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KRAS—skin cancer	2.68e-05	0.000182	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—skin cancer	2.62e-05	0.000178	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HRAS—skin cancer	2.6e-05	0.000177	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KRAS—skin cancer	2.58e-05	0.000175	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HRAS—skin cancer	2.58e-05	0.000175	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—skin cancer	2.58e-05	0.000175	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KRAS—skin cancer	2.55e-05	0.000173	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HRAS—skin cancer	2.5e-05	0.00017	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NRAS—skin cancer	2.49e-05	0.000169	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—skin cancer	2.49e-05	0.000169	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—skin cancer	2.47e-05	0.000168	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HRAS—skin cancer	2.46e-05	0.000167	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—skin cancer	2.45e-05	0.000166	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—skin cancer	2.4e-05	0.000163	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—skin cancer	2.38e-05	0.000162	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—skin cancer	2.36e-05	0.00016	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HRAS—skin cancer	2.34e-05	0.000159	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NRAS—skin cancer	2.32e-05	0.000157	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—skin cancer	2.3e-05	0.000156	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HRAS—skin cancer	2.28e-05	0.000155	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—skin cancer	2.27e-05	0.000154	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—skin cancer	2.24e-05	0.000152	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.22e-05	0.00015	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HRAS—skin cancer	2.2e-05	0.000149	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—skin cancer	2.18e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HRAS—skin cancer	2.17e-05	0.000147	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KRAS—skin cancer	2.15e-05	0.000145	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—skin cancer	2.1e-05	0.000142	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—skin cancer	2.08e-05	0.000141	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KRAS—skin cancer	1.99e-05	0.000135	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—skin cancer	1.91e-05	0.000129	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HRAS—skin cancer	1.82e-05	0.000124	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—skin cancer	1.77e-05	0.00012	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—skin cancer	1.75e-05	0.000118	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HRAS—skin cancer	1.7e-05	0.000115	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ERCC2—skin cancer	1.65e-05	0.000112	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—skin cancer	1.62e-05	0.00011	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—skin cancer	9.88e-06	6.7e-05	CbGpPWpGaD
